Anti-c-myc efficacy block EGFL7 induced prolactinoma tumorigenesis
Resistance to Dopamine agonists therapy is still a key factor that hinders the clinical treatment of prolactinoma. Consequently, a large number of investigations have been carried out to identify novel therapeutic targets. Our previous studies have suggested that the epidermal growth factor-like dom...
Na minha lista:
| Principais autores: | , , , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
De Gruyter
2019-12-01
|
| coleção: | Open Chemistry |
| Assuntos: | |
| Acesso em linha: | https://doi.org/10.1515/chem-2019-0151 |
| Tags: |
Sem tags, seja o primeiro a adicionar uma tag!
|